Lauren Biscaldi

This study challenges the view that history of cardiovascular disease is a key factor in decisions about blood pressure-lowering treatment.

The researchers aimed to derive and validate clinically useful clusters of patients with heart failure with preserved ejection fraction of 50% or greater.